{"news_desk": "National", "print_page": "13", "subsection_name": "Politics", "section_name": "U.S.", "byline": {"original": "By ROBERT PEAR", "person": [{"firstname": "Robert", "rank": 1, "lastname": "PEAR", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "News", "word_count": "964", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}, {"rank": "2", "value": "Senate", "is_major": "N", "name": "organizations"}, {"rank": "3", "value": "United States Politics and Government", "is_major": "Y", "name": "subject"}, {"rank": "4", "value": "Food and Drug Administration", "is_major": "N", "name": "organizations"}, {"rank": "5", "value": "Prices (Fares, Fees and Rates)", "is_major": "N", "name": "subject"}, {"rank": "6", "value": "Collins, Susan M", "is_major": "N", "name": "persons"}, {"rank": "7", "value": "Turing Pharmaceuticals AG", "is_major": "N", "name": "organizations"}, {"rank": "8", "value": "Retrophin Inc", "is_major": "N", "name": "organizations"}, {"rank": "9", "value": "Rodelis Therapeutics", "is_major": "N", "name": "organizations"}, {"rank": "10", "value": "Valeant Pharmaceuticals International Inc", "is_major": "N", "name": "organizations"}], "lead_paragraph": "A bipartisan report says Congress should prevent huge, unjustified cost increases on decades-old prescription medicines that have no competition.", "pub_date": "2016-12-21T07:00:29+0000", "document_type": "article", "source": "The New York Times", "snippet": "A bipartisan report says Congress should prevent huge, unjustified cost increases on decades-old prescription medicines that have no competition....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/12/21/us/21drug/21drug-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/12/21/us/21drug/21drug-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/12/21/us/21drug/21drug-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/12/21/us/21drug/21drug-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/12/21/us/21drug/21drug-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/12/21/us/21drug/21drug-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/12/21/us/politics/prescription-drug-prices.html", "slideshow_credits": null, "blog": [], "_id": "585a289395d0e039260771b2", "headline": {"main": "Senate Aims to Stop Firms From \u2018Buying Up Drugs and Jacking Up Prices\u2019", "print_headline": "Senate Aims to Stop Price Spikes on Prescription Drugs"}}